Guided Biofilm Therapy in the treatment of peri-implant pathology: the CIST protocol updated
This is a presentation of a recently introduced protocol for the treatment of peri-implant pathologies. Based on clinical and scientific data, and a book that is expected to be published by Quintessence at the beginning of 2024, a modification of the protocol known as cumulative interceptive supportive therapy (CIST) is thoroughly discussed. Clinical application of the Guided Biofilm Therapy (GBT) protocol plays a pivotal role in the modified CIST protocol that will be very helpful for clinicians dealing with maintenance of implant patients and treatment of peri-implantitis.
- To offer the clinician the necessary information about how to incorporate GBT in supportive or actual therapy of implant patients.
- To present scientific data about advantages and disadvantages of existing treatment modalities.
- To assist in the decision-making process in peri-implantitis cases.
- To familiarise the audience with the modified CIST protocol for the treatment of peri-implant pathologies.